Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Future Directions for Cost-effectiveness Analyses in Health and Medicine.

Neumann PJ, Kim DD, Trikalinos TA, Sculpher MJ, Salomon JA, Prosser LA, Owens DK, Meltzer DO, Kuntz KM, Krahn M, Feeny D, Basu A, Russell LB, Siegel JE, Ganiats TG, Sanders GD.

Med Decis Making. 2018 Oct;38(7):767-777. doi: 10.1177/0272989X18798833.

PMID:
30248277
2.

Re: Readability Assessment of PCORI Public Abstracts in Relation to Accessibility.

Siegel JE, Gayer CC, Slutsky JR.

Epidemiology. 2017 Nov;28(6):e54. doi: 10.1097/EDE.0000000000000674. No abstract available.

PMID:
28383301
3.

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.

Sanders GD, Neumann PJ, Basu A, Brock DW, Feeny D, Krahn M, Kuntz KM, Meltzer DO, Owens DK, Prosser LA, Salomon JA, Sculpher MJ, Trikalinos TA, Russell LB, Siegel JE, Ganiats TG.

JAMA. 2016 Sep 13;316(10):1093-103. doi: 10.1001/jama.2016.12195. Erratum in: JAMA. 2016 Nov 8;316(18):1924.

PMID:
27623463
4.

Public deliberation in decisions about health research.

Siegel JE, Heeringa JW, Carman KL.

Virtual Mentor. 2013 Jan 1;15(1):56-64. doi: 10.1001/virtualmentor.2013.15.1.pfor2-1301. No abstract available.

5.

Phase I, randomized, double-blind, placebo-controlled, single-dose escalation study of the recombinant factor VIIa variant BAY 86-6150 in hemophilia.

Mahlangu JN, Coetzee MJ, Laffan M, Windyga J, Yee TT, Schroeder J, Haaning J, Siegel JE, Lemm G.

J Thromb Haemost. 2012 May;10(5):773-80. doi: 10.1111/j.1538-7836.2012.04667.x.

6.

Issues concerning feedback about genetic testing and risk of depression.

Wilhelm K, Meiser B, Mitchell PB, Finch AW, Siegel JE, Parker G, Schofield PR.

Br J Psychiatry. 2009 May;194(5):404-10. doi: 10.1192/bjp.bp.107.047514.

PMID:
19407269
7.

Optimism, social support, and adjustment in African American women with breast cancer.

Shelby RA, Crespin TR, Wells-Di Gregorio SM, Lamdan RM, Siegel JE, Taylor KL.

J Behav Med. 2008 Oct;31(5):433-44. doi: 10.1007/s10865-008-9167-2. Epub 2008 Aug 20.

8.

The long and the short of it: associations between 5-HTT genotypes and coping with stress.

Wilhelm K, Siegel JE, Finch AW, Hadzi-Pavlovic D, Mitchell PB, Parker G, Schofield PR.

Psychosom Med. 2007 Sep-Oct;69(7):614-20. Epub 2007 Aug 31.

PMID:
17766691
9.

Reproducibility of platelet function testing.

Hevelow ME, McKenzie SM, Siegel JE.

Lab Hematol. 2007;13(2):59-62.

PMID:
17573283
10.

Relative value in healthcare: cost-effectiveness of interventions.

Siegel JE, Clancy CM.

J Nurs Care Qual. 2006 Apr-Jun;21(2):99-103. Review. No abstract available.

PMID:
16540774
11.

Health and health care status of African-born residents of Metropolitan Washington, DC.

Siegel JE, Horan SA, Teferra T.

J Immigr Health. 2001 Oct;3(4):213-24.

PMID:
16228788
12.

Standardized versus open-ended assessment of psychosocial and medical concerns among African American breast cancer patients.

Shelby RA, Lamdan RM, Siegel JE, Hrywna M, Taylor KL.

Psychooncology. 2006 May;15(5):382-97.

PMID:
16155965
13.

Can we better prioritize resources for cost-utility research?

Neumann PJ, Rosen AB, Greenberg D, Olchanski NV, Pande R, Chapman RH, Stone PW, Ondategui-Parra S, Nadai J, Siegel JE, Weinstein MC.

Med Decis Making. 2005 Jul-Aug;25(4):429-36.

PMID:
16061895
14.

Cost-effectiveness analysis in US healthcare decision-making: where is it going?

Siegel JE.

Med Care. 2005 Jul;43(7 Suppl):1-4. No abstract available.

PMID:
16056002
15.

Federal sponsorship of cost-effectiveness and related research in health care: 1997-2001.

Siegel JE, Byron SC, Lawrence WF.

Value Health. 2005 May-Jun;8(3):223-36.

16.

Abnormalities of hemostasis and abnormal uterine bleeding.

Siegel JE.

Clin Obstet Gynecol. 2005 Jun;48(2):284-94. Review. No abstract available.

PMID:
15805787
17.

Adipose tissue in myocardial infarction.

Su L, Siegel JE, Fishbein MC.

Cardiovasc Pathol. 2004 Mar-Apr;13(2):98-102.

PMID:
15033159
18.

Outcomes research: priorities for an evolving field.

Stryer DB, Siegel JE, Rodgers AB.

Med Care. 2004 Apr;42(4 Suppl):III1-5. No abstract available.

PMID:
15026671
19.

Psychological adjustment among African American breast cancer patients: one-year follow-up results of a randomized psychoeducational group intervention.

Taylor KL, Lamdan RM, Siegel JE, Shelby R, Moran-Klimi K, Hrywna M.

Health Psychol. 2003 May;22(3):316-23.

PMID:
12790260
20.

Treatment regimen, sexual attractiveness concerns and psychological adjustment among African American breast cancer patients.

Taylor KL, Lamdan RM, Siegel JE, Shelby R, Hrywna M, Moran-Klimi K.

Psychooncology. 2002 Nov-Dec;11(6):505-17.

PMID:
12476432
21.

Menorrhagia from a haematologist's point of view. Part II: management.

Siegel JE, Kouides PA.

Haemophilia. 2002 May;8(3):339-47. Review.

PMID:
12010431
22.

Recent evidence on the effectiveness of prenatal care.

McCormick MC, Siegel JE.

Ambul Pediatr. 2001 Nov-Dec;1(6):321-5.

PMID:
11888422
23.

The crisis in local institutional review boards.

Siegel JE, Vaughn A, Baszczewski E.

Ann Intern Med. 2002 Mar 5;136(5):410-1; author reply 410-1. No abstract available.

PMID:
11874318
24.

Does cost-effectiveness analysis make a difference? Lessons from Pap smears. Symposium.

Hagen MD, Garber AM, Goldie SJ, Lafata JE, Mandelblatt J, Meltzer D, Neumann P, Siegel JE, Sox HC Jr, Tsevat J.

Med Decis Making. 2001 Jul-Aug;21(4):307-23. No abstract available.

PMID:
11475387
25.

Hematologic management of gastrointestinal bleeding.

Maltz GS, Siegel JE, Carson JL.

Gastroenterol Clin North Am. 2000 Mar;29(1):169-87, vii. Review.

PMID:
10752021
26.

Community-based interventions: taking on the cost and cost-effectiveness questions.

Siegel JE, Clancy CM.

Health Serv Res. 2000 Dec;35(5 Pt 1):905-9. No abstract available.

27.

Multiple arterial thromboembolisms in a patient with the 20210 A prothrombin gene mutation.

Seeburger JL, Stepak M, Fukuchi SG, Siegel JE, Rolandelli RH.

Arch Surg. 2000 Jun;135(6):721-2.

PMID:
10843373
28.

Distress, personality, and mammography utilization among women with a family history of breast cancer.

Schwartz MD, Taylor KL, Willard KS, Siegel JE, Lamdan RM, Moran K.

Health Psychol. 1999 Jul;18(4):327-32.

PMID:
10431933
29.
30.

Cost-effectiveness analysis and nursing research--is there a fit?

Siegel JE.

Image J Nurs Sch. 1998;30(3):221-2. No abstract available.

PMID:
9753835
31.

Monitoring heparin therapy: APTT results from partial- vs full-draw tubes.

Siegel JE, Bernard DW, Swami VK, Sazama K.

Am J Clin Pathol. 1998 Aug;110(2):184-7.

PMID:
9704617
32.

Effect (or lack of it) of severe anemia on PT and APTT results.

Siegel JE, Swami VK, Glenn P, Peterson P.

Am J Clin Pathol. 1998 Jul;110(1):106-10.

PMID:
9661929
33.

Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group.

Weinstein MC, Siegel JE, Garber AM, Lipscomb J, Luce BR, Manning WG Jr, Torrance GW.

Health Econ. 1997 Sep-Oct;6(5):505-10. No abstract available.

PMID:
9353651
34.

Whose blood is safer? The effect of the stage of the epidemic on screening for HIV.

Litvak E, Siegel JE, Pauker SG, Lallemant M, Fineberg HV, Weinstein MC.

Med Decis Making. 1997 Oct-Dec;17(4):455-63.

PMID:
9343804
35.

Expected hemoglobin decrease following percutaneous transluminal coronary angioplasty.

Jauch W, Kurnik PB, Hanlon SJ, Siegel JE, Matthai WH Jr.

Am J Cardiol. 1997 Jul 1;80(1):71-4.

PMID:
9205023
36.

Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine.

Siegel JE, Torrance GW, Russell LB, Luce BR, Weinstein MC, Gold MR.

Pharmacoeconomics. 1997 Feb;11(2):159-68. Review.

PMID:
10172935
37.

Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine.

Siegel JE, Weinstein MC, Russell LB, Gold MR.

JAMA. 1996 Oct 23-30;276(16):1339-41. Review.

PMID:
8861994
38.

Recommendations of the Panel on Cost-effectiveness in Health and Medicine.

Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB.

JAMA. 1996 Oct 16;276(15):1253-8. Review.

PMID:
8849754
39.

The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine.

Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC.

JAMA. 1996 Oct 9;276(14):1172-7. Review.

PMID:
8827972
40.

Oregon's Medicaid ranking and cost-effectiveness: is there any relationship?

Tengs TO, Meyer G, Siegel JE, Pliskin JS, Graham JD, Weinstein MC.

Med Decis Making. 1996 Apr-Jun;16(2):99-107.

PMID:
8778541
41.

Economic evaluation of HIV testing among intravenous drug users. An analytic framework and its application to Italy.

Villari P, Fattore G, Siegel JE, Paltiel AD, Weinstein MC.

Int J Technol Assess Health Care. 1996 Spring;12(2):336-57.

PMID:
8707505
42.

Clinical problem-solving: diagnosing spousal abuse.

Siegel JE.

N Engl J Med. 1995 Dec 21;333(25):1710-1. No abstract available.

PMID:
7477232
43.

Five-hundred life-saving interventions and their cost-effectiveness.

Tengs TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Weinstein MC, Graham JD.

Risk Anal. 1995 Jun;15(3):369-90.

PMID:
7604170
44.

Evaluation of the immunofluorescence procedure for detection of Giardia cysts and Cryptosporidium oocysts in water.

LeChevallier MW, Norton WD, Siegel JE, Abbaszadegan M.

Appl Environ Microbiol. 1995 Feb;61(2):690-7.

45.

HIV screening of surgeons and dentists: a cost-effectiveness analysis.

Sell RL, Jovell AJ, Siegel JE.

Infect Control Hosp Epidemiol. 1994 Oct;15(10):635-45.

PMID:
7844334
46.

Cost utility of maintenance treatment of recurrent depression with sertraline versus episodic treatment with dothiepin.

Hatziandreu EJ, Brown RE, Revicki DA, Turner R, Martindale J, Levine S, Siegel JE.

Pharmacoeconomics. 1994 Mar;5(3):249-68.

PMID:
10146899
47.

Postchemotherapy rheumatism: is this a menopausal symptom?

Siegel JE.

J Clin Oncol. 1993 Oct;11(10):2051. No abstract available.

PMID:
8410131
48.

Spontaneous hemorrhage associated with accidental brodifacoum poisoning in a child.

Travis SF, Warfield W, Greenbaum BH, Molokisher M, Siegel JE.

J Pediatr. 1993 Jun;122(6):982-4.

PMID:
8501581
49.

Importance of factor Xa in determining the procoagulant activity of whole-blood clots.

Eisenberg PR, Siegel JE, Abendschein DR, Miletich JP.

J Clin Invest. 1993 May;91(5):1877-83.

50.

Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus.

Siegel JE, Krolewski AS, Warram JH, Weinstein MC.

J Am Soc Nephrol. 1992 Oct;3(4 Suppl):S111-9.

PMID:
1457753

Supplemental Content

Loading ...
Support Center